Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas

NCT07010692 is registered in ClinicalTrials.gov with Bruce Robinson, MD as lead sponsor.

NCT NCT07010692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07010692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas
Lead sponsor
Bruce Robinson, MD
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 16, 2025
Completion date
June 30, 2030
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinomas, keratinocyte carcinoma, skin cancer, squamous cell carcinoma